Apr 16, 2019 / 12:30PM GMT
Jack A. Khattar - Supernus Pharmaceuticals, Inc. - Founder, President, CEO, Secretary & Director
Good morning, everyone. Thank you so much for joining us today. We appreciate you making the trip and spending a good portion of your day with us. I'm Jack Khattar, President and CEO of Supernus.
Before we get started, I just want to remind everyone that we will be making forward-looking statements about the business throughout the presentation as well as the Q&A session. So please refer to the SEC filings for all the risk factors associated with our business.
We have a fairly full agenda today. I'll start very briefly with brief introductions and a brief corporate overview, and then we're going to get into the substance of today's meeting, which is our pipeline, specifically, SPN-812, SPN-810, and SPN-604. And then we will have a general Q&A session at the end.
One little detail here. After SPN-812, we will also have a Q&A session. So I will really encourage everyone to please write down your questions and, if you don't mind, no interruptions of the presentation
Supernus Pharmaceuticals Inc Investor Day Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers